Tags

Type your tag names separated by a space and hit enter

Endoscopic Coblation for the treatment of advanced juvenile nasopharyngeal angiofibroma.
Ear Nose Throat J 2012; 91(10):432, 434, 436, 438EN

Abstract

We present 2 cases of advanced juvenile nasopharyngeal angiofibroma (JNA) to illustrate the advantages of endoscopic Coblation-assisted resection of intranasal extensions of these masses. Both patients-an 11-year-old boy and a 14-year-old boy-presented with a large, extensive mass (Radkowski stage IIIb and Fisch stage IVb in both cases). After embolization was performed on each patient, his JNA was partially ablated via an endoscopic approach with the Coblator II Surgery System with an EVac Xtra Plasma Wand in conjunction with an image-guided navigation system. Both patients experienced resolution of their nasal obstruction with removal of the intranasal extension of the tumor. Coblation allowed for a controlled debulking of the tumors with less blood loss and without the need for multiple instruments. To the best of our knowledge, our report is one of the first to describe image-guided endoscopic Coblation of advanced JNA tumors. Future studies in adequately sized populations are needed to determine the safety and effectiveness of Coblation-assisted endoscopic removal of both advanced and lower-stage JNAs.

Authors+Show Affiliations

Department of Otorhinolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73126-0901, USA.

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

23076852

Citation

Pierson, Brandon, et al. "Endoscopic Coblation for the Treatment of Advanced Juvenile Nasopharyngeal Angiofibroma." Ear, Nose, & Throat Journal, vol. 91, no. 10, 2012, pp. 432, 434, 436, 438.
Pierson B, Powitzky R, Digoy GP. Endoscopic Coblation for the treatment of advanced juvenile nasopharyngeal angiofibroma. Ear Nose Throat J. 2012;91(10):432, 434, 436, 438.
Pierson, B., Powitzky, R., & Digoy, G. P. (2012). Endoscopic Coblation for the treatment of advanced juvenile nasopharyngeal angiofibroma. Ear, Nose, & Throat Journal, 91(10), pp. 432, 434, 436, 438.
Pierson B, Powitzky R, Digoy GP. Endoscopic Coblation for the Treatment of Advanced Juvenile Nasopharyngeal Angiofibroma. Ear Nose Throat J. 2012;91(10):432, 434, 436, 438. PubMed PMID: 23076852.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Endoscopic Coblation for the treatment of advanced juvenile nasopharyngeal angiofibroma. AU - Pierson,Brandon, AU - Powitzky,Rosser, AU - Digoy,G Paul, PY - 2012/10/19/entrez PY - 2012/10/19/pubmed PY - 2013/12/16/medline SP - 432, 434, 436, 438 JF - Ear, nose, & throat journal JO - Ear Nose Throat J VL - 91 IS - 10 N2 - We present 2 cases of advanced juvenile nasopharyngeal angiofibroma (JNA) to illustrate the advantages of endoscopic Coblation-assisted resection of intranasal extensions of these masses. Both patients-an 11-year-old boy and a 14-year-old boy-presented with a large, extensive mass (Radkowski stage IIIb and Fisch stage IVb in both cases). After embolization was performed on each patient, his JNA was partially ablated via an endoscopic approach with the Coblator II Surgery System with an EVac Xtra Plasma Wand in conjunction with an image-guided navigation system. Both patients experienced resolution of their nasal obstruction with removal of the intranasal extension of the tumor. Coblation allowed for a controlled debulking of the tumors with less blood loss and without the need for multiple instruments. To the best of our knowledge, our report is one of the first to describe image-guided endoscopic Coblation of advanced JNA tumors. Future studies in adequately sized populations are needed to determine the safety and effectiveness of Coblation-assisted endoscopic removal of both advanced and lower-stage JNAs. SN - 1942-7522 UR - https://www.unboundmedicine.com/medline/citation/23076852/Endoscopic_Coblation_for_the_treatment_of_advanced_juvenile_nasopharyngeal_angiofibroma_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=23076852.ui DB - PRIME DP - Unbound Medicine ER -